


























































published: 07 June 2013
doi: 10.3389/fendo.2013.00070
Prevalence of olfactory and other developmental
anomalies in patients with central hypogonadotropic
hypogonadism
Elisa Della Valle1, Silvia Vezzani 1,Vincenzo Rochira1,2, Antonio Raffaele Michele Granata2, Bruno Madeo2,
Elisabetta Genovese3, Elisa Pignatti 1, Marco Marino1, Cesare Carani 1,2 and Manuela Simoni 1,2*
1 Unit and Chair of Endocrinology and Metabolism, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena,
Italy
2 Department of Medicine, Endocrinology, Metabolism and Geriatrics, Azienda USL of Modena, Modena, Italy
3 Department of Otolaryngology and Head and Neck Surgery, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy
Edited by:
Silvano Bertelloni, Santa Chiara
University-Hospital, Italy
Reviewed by:
Tim Barrett, University of
Birmingham, UK
Eli Hershkovitz, Soroka Medical
University Center, Israel
*Correspondence:
Manuela Simoni , Section of
Endocrinology, Geriatrics and
Metabolism, Department of
Biomedical, Metabolic and Neural
Sciences, University of Modena and
Reggio Emilia, NOCSAE, Via Giardini
1355, Modena 41126, Italy
e-mail: manuela.simoni@unimore.it
Introduction: Hypogonadotropic hypogonadism (HH) is a heterogeneous disease caused
by mutations in several genes. Based on the presence of hyposmia/anosmia it is distin-
guished into Kallmann syndrome (KS) and isolated HH. The prevalence of other develop-
mental anomalies is not well established.
Methods: We studied 36 patients with HH (31 males, 5 females, mean age 41.5), 9 with
familial and 27 with sporadic HH (33 congenital, 3 adult-onset), by physical examination,
smell test (BSIT Sensonics), audiometry, renal ultrasound, and magnetic resonance imag-
ing of the olfactory structures.
Results: Based on the smell test, patients were classified as normosmic (n = 21, 58.3%)
and hypo/anosmic (n = 15, 41.6%). Hypoplasia/agenesis of olfactory bulbs was found in
40% of patients (10/25; 75% hypo/anosmic, 7.6% normosmic, p < 0.01, Fisher’s test).
Remarkably, olfactory structures were normal in two anosmic patients, while one nor-
mosmic patient presented a unilateral hypoplastic bulb. Fourteen of 33 patients (42.4%)
presented neurosensorial hearing loss of various degrees (28.5% hypo/anosmic, 52.6%
normosmic, p = NS). Renal ultrasound revealed 27.7% of cases with renal anomalies
(26.6% hypo/anosmic, 28.5% normosmic, p = NS). At least one midline defect was found
in 50% of the patients (53.3% hypo/anosmic, 47.6% normosmic, p = NS), including abnor-
mal palate, dental anomalies, pectus excavatum, bimanual synkinesis, iris coloboma,
and absent nasal cartilage. Anamnestically 4/31 patients reported cryptorchidism (25%
hypo/anosmic, 5.2% normosmic, p = NS).
Conclusion: Hypo/anosmia is significantly related to anatomical anomalies of the olfac-
tory bulbs/tracts but the prevalence of other developmental anomalies, especially midline
defects and neurosensorial hearing loss, is high both in HH and KS and independent of
the presence of anosmia/hyposmia. From the clinical standpoint KS and normosmic HH
should be considered as the same complex, developmental disease.
Keywords: developmental anomalies, central hypogonadotropic hypogonadism, Kallmann syndrome,
hypothalamic-pituitary-gonadal axis, neurosensorial hearing loss, midline defects, smell test
INTRODUCTION
Hypogonadotropic hypogonadism (HH) is characterized by
a defective embryologic development of the Gonadotropin-
releasing hormone (GnRH) pulse generator and the hypothalamo-
pituitary-gonadal axis, with a prevalence from 1/4,000–1/10,000
in male and 1/40,000 in females (Grumbach, 2005). During
normal embryonic development, the GnRH and olfactory neu-
rons migrate together from the nasal olfactory epithelium to the
basal hypothalamus, therefore a defect in this process may cause
hypo/anosmic hypogonadism. The inability to perceive olfactory
stimuli results from aplasia or hypoplasia of the olfactory bulbs
and tracts. To date, hypogonadism associated with an olfactory
deficit is defined as Kallmann syndrome (KS) and is distinct from
normosmic HH (nHH), however both diseases share anatomi-
cal and genetic etiopathogenesis with common features. Many
recent studies described several genes implicated in HH with dif-
ferent expressions also when the same mutation is present in
different subjects within the same family (Pitteloud et al., 2006;
Trarbach et al., 2006; Dodé et al., 2007), thus progressively thin-
ning the border between KS and nHH. In fact, a recent study
described mutations in genes previously thought to regulate pri-
marily GnRH secretions in nHH (GNRHR, TAC3, KISS1, and
KISS1R) in association with both normosmia and hyposmia;
the precise mechanism is unclear but oligogenicity is a plausible
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reason (Lewkowitz-Shpuntoff et al., 2012). Previously, mutations
in genes such as FGFR1, FGF8, PROK2, and PROKR2 have been
shown both in KS and in nHH, reinforcing the hypothesis of a
pathophysiological overlap between these diseases. The majority
of cases of HH are sporadic, but gene mutations or deletions can
be detected in about 20% of cases of KS and in over 50% of cases
of nHH, so that the old denomination “idiopathic” HH appears
now obsolete (Simoni and Nieschlag, 2007). HH may be classified
according to the severity of the pubertal defect as “complete,” if
there is no evidence of puberty, or “incomplete,” if there is any
evidence of sexual maturation (Burris et al., 1988). HH may also
occur in adult age, commonly in the setting of infertility, in patients
with completed puberty by the age of 18 years, so we can differ-
entiate “congenital HH” and “adult-onset HH” (Nachtigall et al.,
1997). HH generally requires lifelong therapy, however cases of
spontaneous reversal later in life have been reported in about 10%
of patients with either absent or partial puberty (Raivio et al.,
2007). HH is a heterogeneous disease characterized not only by
alteration of hypothalamo-pituitary-gonadal axis and/or olfactory
structures but also by many developmental anomalies such as mid-
line defects, hearing loss, renal anomalies, cryptorchidism. Only
few studies reported the prevalence of these clinical features in KS
patients, showing a large variability, and only rarely a comparison
between KS and nHH was made (Quinton et al., 2001; Kaplan et al.,
2010; Bonomi et al., 2012). In this study we assessed the phenotyp-
ical aspects of a normosmic and hypo/anosmic population of HH
patients, demonstrating that, except for anatomical anomalies of
the olfactory structures expectedly more frequent in hypo/anosmic
patients, the other developmental defects are very common and are
similarly found both in hypo/anosmic and normosmic patients.
MATERIALS AND METHODS
SUBJECTS
The study, partially prospective and partially retrospective, was
approved by the local ethics committee and all subjects gave their
written authorization to participation. From February 2009 to
April 2012 we enrolled 36 patients, 31 males and 5 females (mean
age 41.5), 9 with familial and 27 sporadic HH, 33 congenital, and
3 adult-onset, followed up at the Unit and Chair of Endocrinology
and Metabolism of the University of Modena and Reggio Emilia,
Italy. They fulfilled the following criteria: (1) absent or incomplete
pubertal development by the age of 18 years, (2) low serum sex
steroid levels with inappropriately low or normal gonadotropin
levels (serum testosterone <100 ng/dl in men, primary amenorrea
in women), (3) absence of other functional pituitary deficien-
cies or pituitary anomalies, (4) absence of causes of secondary
hypogonadism. At the time of inclusion, 24 male patients were
treated with androgenic replacement therapy, five male patients
with gonadotropins, two men had withdrawn the therapy since
many years (one because of spontaneous reversal HH and one
because of poor compliance), three female patients were treated
with estroprogestinic drugs,one woman was never treated,and one
woman had stopped transdermic estrogens since many months.
METHODS
The patients were interviewed for medical, pharmacological and
familial history, cryptorchidism, and pubertal development. Each
patient underwent general physical examination, including search-
ing middle line defects such us pectus excavatum, iris coloboma,
absent nasal cartilage. Ogival palate, defined as high and narrow
hard palate arch, cleft/lip palate, and absence of one or more teeth
were assessed by clinical oral examination and anamnestically.
Patients were asked to perform movements of one hand to assess
the presence of involuntary synchronous mirror image movements
in the opposite hand (bimanual synkinesis). In addition the fol-
lowing instrumental procedures were performed: audiometry in
33 patients, renal ultrasound in 36 patients (Esaote, MyLab ™70
XVision, Bio-Tek Instruments Inc.), nuclear magnetic resonance
(NMR) of the olfactory structures in 25 patients (Philips Intera 3T
Magnetic Resonance Imaging System). Sense of smell was tested
by the Brief Smell Identification Test (BSIT Sensonics, NJ, USA),
a microencapsulated odor “scratch and sniff” test with 12 items.
Olfactory score of each subject was then interpreted using the age-
and sex-related normative classification system described in the
specific manual.
STATISTICAL ANALYSIS
For statistical analysis we used the software SigmaPlot (version
11.00 for Windows; Systat Software Inc., San Jose, CA, USA).
Fisher’s exact test was used to determine statistical significance
comparing prevalence of the anomalies between the hypo/anosmic
group and normosmic group. All p-values are two-sided and
p < 0.01 were considered significant.
RESULTS
SMELL AND OLFACTORY STRUCTURES
Based on the smell test, patients were classified as normosmic
(n = 21, 58.3%) and hypo/anosmic (n = 15, 41.6%). Hypopla-
sia/agenesis of olfactory bulbs was found in 10/25 patients
(75% hypo/anosmic, 7.6% normosmic, p < 0.01) (Table 1): five
bilateral and one unilateral hypoplasia, four bilateral agenesis.
Remarkably, olfactory structures were normal in three anosmic
patients, while one normosmic patient presented a unilateral
hypoplastic bulb.
HEARING
Fourteen of 33 patients presented neurosensorial hearing loss
of various degrees (28.5% hypo/anosmic, 52.6% normosmic,
p = NS) (Table 1), three cases unilateral, more frequently of
medium-mild entity and in all cases for high frequencies. Of par-
ticular interest, we found bilateral absence of acoustic stapedius
reflex in two hypo/anosmic patients and unilateral absence of
acoustic stapedius reflex in one normosmic patient, not associated
with hearing loss.
KIDNEYS
Renal ultrasound revealed renal anomalies in 10/36 patients
(26.6% hypo/anosmic, 28.57% normosmic, p = NS) (Table 1). In
the normosmic group we found four cases of bilateral cysts, one
case of unilateral hypoplasia, and one patient with hypertrophied
column of Bertin (not considered a pathological feature but an
anatomic variant); in the hypo/anosmic group we found two cases
of unilateral agenesis, one case of bilateral cysts, and one case of
unilateral nephrectomy because of renal cell carcinoma.
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Table 1 | Percentages of developmental anomalies in HH patients.
Developmental anomalies Total patients Hypo/anosmic HH Normosmic HH P (Fisher’s test)
Hypoplasia/agenesis of olfactory bulbs 40% (10/25) 75% (9/12) 7.6% (1/13) 0.001
Neurosensorial hearing loss 42.4% (14/33) 28.5% (4/14) 52.6% (10/19) 0.286
Renal anomalies 27.7% (10/36) 26.6% (4/15) 28.5% (6/21) 1
Midline defects (total) 50% (18/36) 53.3% (8/15) 47.6% (10/21) 1
Abnormal palate 44.4% (16/36) 40% (6/15) 47.6% (10/21) 0.741
Teeth agenesis 16.6% (6/36) 20% (3/15) 14.2% (3/21) 0.677
Supernumerary teeth 5.5% (2/36) 6.6% (1/15) 4.7% (1/21) 1
Pectus excavatum 5.5% (2/36) 6.6% (1/15) 4.7% (1/21) 1
Bimanual synkinesis 5.5% (2/36) 6.6% (1/15) 4.7% (1/21) 1
Iris coloboma 5.5% (2/36) 13.3% (2/15) (0/21) 0.167
Absent nasal cartilage 5.5% (2/36) 13.3% (2/15) (0/21) 0.167
Cryptorchidism 12.9% (4/31) 25% (3/12) 5.2% (1/19) 0.272
MIDLINE DEVELOPMENT
At least one midline defects was found in 18/36 patients
(53.3% hypo/anosmic, 47.6% normosmic, p = NS): 16/36 abnor-
mal palate, specifically 15 cases of ogival palate and 1 case of
cleft-lip palate (40% hypo/anosmic, 47.6% normosmic, p = NS),
6/36 agenesis of one or more teeth (20% hypo/anosmic, 14.2%
normosmic, p = NS) and 2/36 supernumerary incisors (6.6%
hypo/anosmic, 4.7% normosmic, p = NS), 2/36 pectus exca-
vatum (6.6% hypo/anosmic, 4.7% normosmic, p = NS), 2/36
bimanual synkinesis (6.6% hypo/anosmic, 4.7% normosmic,
p = NS), 2/36 iris coloboma, and absent nasal cartilage (13.3%
hypo/anosmic, 0% normosmic, p = NS). The latter anomalies
were present together in two hypo/anosmic patient (one unilat-
eral and one bilateral coloboma) and the patient with bilateral
coloboma presented also other particular features: blepharophi-
mosis,dystopia cantorum,oblique eye,microphthalmia,flat occip-
ite, prognathism, bilateral clinodactyly of the fifth finger, bilateral
elbow valgus.
CRYPTORCHIDISM
None of the patients was currently cryptorchid. Anamnestically
4/31 patients reported having been treated for cryptorchidism
(25% hypo/anosmic, 5.2% normosmic, p = NS), bilateral in three
cases and treated with surgery, and unilateral in one case treated
pharmacologically. Concerning the female gonads, we found a
unilateral ovarian agenesis in one normosmic patient.
DISCUSSION
Before the discovery, in the last years, of the many genes implicated
in the pathogenesis of HH, some studies, designed to compare the
overall severity of HH between KS and nHH patients, suggested
a more severe reproductive phenotype in anosmic patients, with-
out taking into account the clinical heterogeneity of the disease.
Recent studies compared the genotype-phenotype relationships
(Salenave et al., 2008; Brioude et al., 2010; Sarfati et al., 2010),
but to date the prevalence of clinical features of HH, especially
of non-reproductive and non-olfactory anomalies, has not been
reported in detail. Although in our study the relative small number
of patients precludes really meaningful comparison between the
two subgroups of patients, some comparison with the available
scientific literature is possible. At odds with our results, Quinton
et al. (2001) conducted the clinical evaluation of a large patient
sample (170 males and 45 females) finding a phenotypic separa-
tion between KS and nHH, even if this study lacked statistical
analysis. In this study, mirror movements and neurosensorial
deafness were observed only in KS patients, with a percentage
of 31 and 8% respectively. Conversely, in our population, these
anomalies were present in both groups and hearing defects were
even more frequent in normosmic than in hypo/anosmic patients
although without significant difference. Quinton et al. (2001)
also described a prevalence of cryptorchidism nearly three times
greater in KS than in nHH, despite comparable testicular vol-
umes. As regards this anomaly in our patients, we found no
significant difference between the two groups. Noteworthy, the
prevalence of cryptorchidism in normosmic patients was sim-
ilar to that reported in a study of a large sample of 315 HH
patient in both KS and nHH patients (Bhagavath et al., 2006),
and the prevalence in hypo/anosmic patients was similar to that
reported in a study of Kaplan et al. (2010) in five KS patients.
In a recent study, Bonomi et al. (2012) found a prevalence of
cryptorchidism of 35% in KS patients and 10% in nHH patients.
Pitteloud et al. (2002) reported an higher prevalence of cryp-
torchidism (40%) in HH patients with absent pubertal develop-
ment compared with patients with some evidence of prior pubertal
development (5%). We cannot compare our results to this study
because our subjects were not classified according to complete or
incomplete HH, since at the time of evaluation, many patients
had been treated with testosterone or gonadotropins for many
years.
The prevalence of at least one midline defect in our study group
was high (50%) and nearly equal between hypo/anosmic and nor-
mosmic patients, while in the study of Bonomi et al. (2012) this
was only 6.6% and higher in KS than in nHH patients. Abnor-
mal palate was very frequent in both groups of our study, mainly
ogival palate, however cleft-lip palate, iris coloboma, and absent
nasal cartilage were found only in hypo/anosmic HH. The rarity
of cleft-lip palate was in line with previous studies (Kaplan et al.,
2010). We found absence of at least one tooth (lower molars and
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wisdom teeth) in both group without significant difference. In the
literature, dental agenesis was reported in KS with a prevalence
of 5–10% (Bailleul-Forestier et al., 2010), lower than the preva-
lence in our hypo/anosmic patients, and was rarely reported in
nHH (Pitteloud et al., 2006). In addition, we found two cases of
supernumerary incisors not described in association with HH so
far, although these data were not assessed by orthopantomograms.
Some studies reported bimanual synkinesis only in KS with differ-
ent prevalence ranging from 4.1% (Bonomi et al., 2012) to 31%
(Quinton et al., 2001), while we reported this anomaly in both
group without significant difference.
We found high prevalence (47% of total patients) of neurosen-
sorial hypoacusia of different degrees, especially medium-mild,
bilateral absence of acoustic stapedius reflex in two hypo/anosmic
patients and unilateral absence of acoustic stapedius reflex in
one normosmic patient, not associated with hearing loss. The
latter anomaly may reflect a neuronal or mechanical alteration
and requires further examinations to define the cause. The preva-
lence of hearing loss in HH was reported to date only in KS with
high variability between several studies ranging from 2.1 to 40%
(Kaplan et al., 2010; Bonomi et al., 2012). Our study is in line
with the literature, with a prevalence of 28.5% in hypo/anosmic
subjects, and demonstrates, in addition, that this anomaly can be
found also in normosmic patients, although without significant
difference.
Concerning renal anomalies, radiological studies of subjects
with X-linked form of KS have shown that up to 40% of patients
present an absent kidney unilaterally (Kirk et al., 1994), but also
other anomalies have been reported such as urinary-tract dupli-
cation (Wegenke et al., 1975), hydronephrosis (Zenteno et al.,
1999), renal diverticulum (Lieblich et al., 1982), horseshoe or
rotated kidney (AbuJbara et al., 2004), multicystic dysplastic kid-
ney, and vesicoureteral reflux (Sato et al., 2004). Bonomi et al.
(2012) reported a much lower prevalence of renal agenesis/aplasia
in KS (3.1%) and also described a case of renal agenesis in
a nHH patient. In our hypo/anosmic group, the prevalence of
kidney anomalies was 26.6%, similar to the data reported in
the literature (Sato et al., 2004; Kaplan et al., 2010), but we
found only two2 cases of renal agenesis. In the total popula-
tion, this prevalence was nearly 28% without significant difference
between the two groups. Interestingly ultrasound revealed five
cases of bilateral cysts, more frequent in normosmic patients.
Deeb et al. (2001) described two cases of antenatally diagnosed
multicystic kidneys in two brothers with KS features but without
KAL1 mutations. Anosmin-1, encoded by KAL1, immunolocalizes
early in the ureteric bud brunches and has a role in mediating
cell adhesion during growth of the mesonephric duct/ureteric
bud lineage. Since dysplastic renal tubules are poorly branched
derivatives of the ureteric bud that terminate in cystic dila-
tions, it is supposed that KAL1 mutations can generate renal
dysplasia as well as agenesis. However, cases of renal malfor-
mations are reported in members of families with KS indi-
viduals with normal KAL1 genotype (Colquhoun-Kerr et al.,
1999), suggesting the involvement of other genes. Multicystic kid-
neys tend to involute prenatally or in early childhood, therefore
cases of renal agenesis detected in older patients may originate
as multicystic dysplastic kidneys which subsequently regress.
These malformed organs are often surgically removed because
of the risk of hypertension and renal tumor development. In
our hypo/anosmic population, we found one case of nephrec-
tomy for renal carcinoma in a patient with several features of the
Charge Syndrome (cleft-lip palate, pectus excavatum, unilateral
iris coloboma, absent nasal cartilage, medium-severe neurosen-
sorial hypoacusia, unilateral cryptorchidism); according to our
knowledge this is the first case of a renal cell carcinoma in a HH
patient.
Koenigkam-Santos et al. (2011) recently showed that olfactory
bulb and sulcus aplasia were the most common findings in KS
patients and demonstrated agreement between MRI findings and
the smell test, especially the presence of bulb aplasia and anosmia
were consistent. Therefore, MRI of olfactory structures is impor-
tant to confirm the results of smell test, even if normal olfactory
bulb images have been reported in a few KS patients (Vogl et al.,
1994; Quinton et al., 1996) and, conversely, one normosmic subject
showed a hypoplastic left olfactory bulb (Lewkowitz-Shpuntoff
et al., 2012). This disagreement between the MRI findings and
the smell test was present also in our study. In fact we described
three hypo/anosmic patients with normal olfactory structures and
without evidence of an upper airway acquired anomaly so that
other possible causes of reduced sense of smell exist. Also we
assume that the only normosmic subject with unilateral hypoplas-
tic olfactory bulb may have a mild hyposmia not revealed with
the smell test, or that the contralateral bulb compensates the
hypoplastic bulb.
CONCLUSION
Olfactory defects are significantly related to anatomical anomalies
of the olfactory bulbs/tracts but the prevalence of other develop-
mental anomalies, especially midline defects and neurosensorial
hearing loss, is high both in nHH and KS independently of the
presence of anosmia/hyposmia. From the clinical standpoint KS
and nHH should be considered as the same complex disease.
As a matter of fact, recently hypo/anosmic patients with muta-
tions in genes previously associated only with nHH are reported
in literature (Lewkowitz-Shpuntoff et al., 2012), confirming that
KS and nHH are two different expression of the same pathol-
ogy. Anosmia/hyposmia in the presence of apparently normal
olfactory bulbs is intriguing and suggests that obviously other
causes for this symptom must exist. In this respect the recent
description of previously unrecognized, specific anomalies of the
ethmoid bone is interesting (Maione et al., 2013). Further studies
with a larger sample of patients need to confirm our results and
to find other anomalies associated with this syndrome. Finally,
detailed genetic analysis will allow precise genotype-phenotype
characterization.
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